HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human placental lactogen in pre-eclampsia.

Abstract
Serum placental lactogen (hPL) was measured in serial blood samples obtained from 663 pregnant women at weekly intervals from 36 to 40 weeks. The group included 231 women with pre-eclampsia. Levels of hPL were significantly elevated in primigravidae with this condition but not in multigravidae. In all groups hPL levels were significantly reduced in association with growth retardation, but the clinical value of this observation appeared to be greater in multigravidae than in primigravidae. It is suggested that in primigravidae with pre-eclampsia maternal hPL levels reflect both the pathology of the disease as well as the condition of the fetus.
AuthorsB C Obiekwe, D Sturdee, B L Cockrill, T Chard
JournalBritish journal of obstetrics and gynaecology (Br J Obstet Gynaecol) Vol. 91 Issue 11 Pg. 1077-80 (Nov 1984) ISSN: 0306-5456 [Print] England
PMID6498121 (Publication Type: Journal Article)
Chemical References
  • Placental Lactogen
Topics
  • Birth Weight
  • Female
  • Fetal Distress (blood)
  • Fetal Growth Retardation (blood)
  • Humans
  • Infant, Newborn
  • Parity
  • Placental Lactogen (blood)
  • Pre-Eclampsia (blood)
  • Pregnancy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: